Method for increasing tumor sensitivity to chemotherapy

Surgery – Body protecting or restraining devices for patients or infants – Restrainers and immobilizers

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

604 20, 604 52, 514557, A61N 100

Patent

active

050055887

ABSTRACT:
Drug-resistant tumor cells are rendered drug-sensitive by administering to the tumor cells a pump-affecting compound which suppresses the pumping action of P-glycoprotein on the tumor cells. In the case where the tumor cells have higher .beta.-glucuronidase activity than that of the surrounding tissues, the pump-affecting compound is in the form of a .beta.-D-glucuronide.

REFERENCES:
patent: 4337760 (1982-07-01), Rubin
patent: 4424348 (1984-01-01), Rubin
patent: 4481195 (1984-11-01), Rubin
patent: 4490523 (1984-12-01), Rubin et al.
Hurwitz, D., "Attempts at Site-Directed Experimental Chemotherapy with Antibody Drug-Conjugates," Optimization of Drug Delivery, Alfred Benzon Symposium 17. Editors: Hans Bundgaard, Anne Bagger Hansen, Helmer Kofod, Munksgaard, Copenhagen 1982.
Kartner, N. and Ling, V., "Multidrug Resistance in Cancer," Sci. Amer., Mar. 199, pp. 44-51.
Juranka et al., "P-Glycoprotein: Multidrug-resistance and a superfamily of membrane associated transport proteins," FAS, Dec. 1989 3(14) pp. 2583-2592.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for increasing tumor sensitivity to chemotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for increasing tumor sensitivity to chemotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for increasing tumor sensitivity to chemotherapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2027076

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.